GlaxoSmithKline launches Relenza stockpiling programme
This article was originally published in Scrip
Executive Summary
US employers can purchase doses of GlaxoSmithKline's antiviral Relenza (zanamivir) or reserve specified quantities for eventual purchase in the event of an influenza pandemic under a new stockpiling programme.